Related Experiment Videos
Focal glomerulosclerosis in Hodgkin's disease necessitating peritoneal dialysis
B L Graham1, J Rubin, J C Files
1Department of Medicine, University of Mississippi Medical Center, Jackson 39216.
Insights
A teenage boy with nephrotic syndrome and focal segmental glomerulosclerosis experienced remission after chemotherapy for Hodgkin's disease. This case highlights the potential link between these conditions and treatment outcomes.
Area of Science:
- Nephrology
- Oncology
- Pediatric Nephrology
Background:
- Focal segmental glomerulosclerosis (FSGS) is a significant cause of nephrotic syndrome in adolescents.
- Hodgkin's disease (HD) is a malignancy of the lymphatic system, typically affecting young adults.
- The co-occurrence of FSGS and HD is rare, presenting unique clinical challenges.
Observation:
- A 16-year-old male presented with nephrotic syndrome secondary to FSGS.
- Diagnosis of Hodgkin's disease was established six months after the initial FSGS presentation.
- Initial high-dose corticosteroid therapy for nephrotic syndrome was ineffective, necessitating peritoneal dialysis for fluid management.
Findings:
- Two courses of chemotherapy for Hodgkin's disease led to the remission of nephrotic syndrome.
- This suggests a potential paraneoplastic or treatment-related effect of Hodgkin's disease on FSGS.
- Resolution of nephrotic syndrome occurred despite the underlying FSGS pathology.
Implications:
- Chemotherapy for Hodgkin's disease may be a viable treatment strategy for concurrent nephrotic syndrome.
- This case underscores the importance of considering underlying malignancies in adolescent nephrotic syndrome.
- Further research is warranted to explore the relationship between hematologic malignancies and glomerular diseases.
Abstract:
A 16-year-old white boy had nephrotic syndrome due to focal segmental glomerulosclerosis six months before the diagnosis of Hodgkin's disease was established. Peritoneal dialysis was necessary for volume control after one month of unsuccessful therapy with high doses of corticosteroids. Nephrosis remitted after two courses of chemotherapy.